Profhilo® is a new breakthrough skin treatment developed by IBSA and marketed by Alma in India.
This anti-ageing treatment is an introduction of a totally new category in the injectables market. The breakthrough is neither a dermal filler, nor a skin revitalizer. It is an injectable, stabilised hyaluronic acid (HA)-based product, designed to remodel multi-layer skin tissue.
Profhilo® is composed of a highly-pure HA produced according to a patented technology – NAHYCO. Its unique composition features the highest concentrations of hyaluronic acid available in the market. It contains 64 mg of pure HA, the highest concentration of HA, produced without the use of chemical cross-linking agents (BDDE). This new breakthrough anti-ageing product treats the source of ageing and not just the symptoms. Bio-Remodelling of skin tissues works in the below mentioned areas:
•Stimulates the fibroblast cells, thereby increasing collagen and elastin production.
•Activates the keratinocytes to increase the synthesis of collagen and elastin.
•Preserves and encourages the viability of adipocytes that affect the quality of adipose tissue.
Profhilo’s BAP (Bio Aesthetic points) injection technique was clinically tested for maximum efficiency and client comfort, revolutionising the injectables treatment. The product is available in 56 countries and over 1,500,000 treatments preformed as of July 2020. It has also received several awards for being the best product.